1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Otsuka

Anonymous board for Otsuka


Sort By:
Title
Replies ↓ Views
Last Message
  1. Anonymous
    Replies:
    296
    Views:
    40,050
  2. anonymous
    Replies:
    285
    Views:
    78,979
  3. Anonymous
    Replies:
    253
    Views:
    78,129
  4. Anonymous
    Replies:
    239
    Views:
    43,995
  5. Anonymous
    Replies:
    233
    Views:
    41,889
  6. Anonymous
    Replies:
    187
    Views:
    41,413
  7. Anonymous
    Replies:
    165
    Views:
    46,508
  8. Anonymous
    Replies:
    156
    Views:
    22,724
  9. Anonymous
    Replies:
    141
    Views:
    13,406
  10. Anonymous
    Replies:
    140
    Views:
    22,136
  11. Anonymous
    Replies:
    125
    Views:
    26,956
  12. anonymous
    Replies:
    122
    Views:
    24,250
  13. Anonymous
    Replies:
    118
    Views:
    19,243
  14. anonymous
    Replies:
    113
    Views:
    14,843
  15. Anonymous
    Replies:
    107
    Views:
    8,327
  16. Anonymous
    Replies:
    97
    Views:
    15,288
  17. Anonymous
    Replies:
    96
    Views:
    43,211
  18. Anonymous
    Replies:
    92
    Views:
    9,685
  19. anonymous
    Replies:
    86
    Views:
    26,907
  20. Anonymous
    Replies:
    74
    Views:
    28,730

Thread Display Options

Loading...